BRAF Biomarkers
John was diagnosed with metastatic melanoma his junior year of college. Listen as he shares with Jillian what it was like being diagnosed and how he began his treatment journey.
Information on melanoma – Patient website
Educational patient website on risk factors, diagnosis and treatment of melanoma, including a glossary to help patients understand their pathology report (in German and French).
Brain atrophy in MS – Early therapy with ZEPOSIA® reduces cognitive decline
Brain atrophy in MS patients often leads to cognitive impairment, limiting their daily life and quality of life. At this year's EAN Congress 2023, international experts discussed how to reduce brain atrophy and presented new safety data on Ozanimod therapy over six years
Melanoma & RCC expert interview with Prof. Larkin
Expert Interviews Series: Leading the way through the treatment jungle in melanoma and RCC with Prof. Larkin; Topics: Treatment landscape and therapy choices in melanoma and RCC, AE management of dual-IO therapies
John was diagnosed with metastatic melanoma his junior year of college. Listen as he shares with Jillian what it was like being diagnosed and how he began his treatment journey.